| Pharmaceutical active ingredients: |
| Lecithin |
| Available forms, composition and doses of Ovovitellin: |
| N / A |
| Ovovitellin medical category: |
| Human:Cholagogues, cholelitholytics and hepatic protectorsSupplements and adjuvant therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V06DB - Fat, carbohydrates, proteins, minerals, vitamins, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ovoresta M | Ethinyl Estradiol; Lynestrenol | Organon |
| Ovoresta Micro | Ethinyl Estradiol; Lynestrenol | Organon |
| Ovosiston | Chlormadinone Acetate; Mestranol | Jenapharm |
| Ovostat | Ethinyl Estradiol; Lynestrenol | Organon |
| Ovo-Vinces | Estriol | Dr. August Wolff Arzneimittel |
| Ovowop | Estrone; Ethinyl Estradiol | HorFerVit Pharma |
| Ovplex | Angelica Sinensis; Apis Mellifica; Belladonna; Caulophyllum Thalictroides; Charcoal Activated; Cimicifuga Racemosa; Dioscorea Villosa; Iodine; Magnesium Phosphate Dibasic; Oophorinum; Pituitary Posterior; Sepia Officinalis L; Zinc | Bio Active Canada |
| Ovral | Ethinyl Estradiol; Norgestrel | Wyeth |
| Ovral 21 | Ethinyl Estradiol; Norgestrel | Wyeth |
| Ovral 28 | Ethinyl Estradiol; Norgestrel | Wyeth |